Franklin Resources’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Franklin Resources’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,185	Closed	-$115K	–	2491
2022 Q1	$115K	Hold	2,185	–	–	﹤0.01%	2273
2021 Q4	$121K	Hold	2,185	–	–	﹤0.01%	2318
2021 Q3	$169K	Buy	+2,185	New	+$185K	﹤0.01%	2262
2017 Q3	–	Sell	-2,266	Closed	-$1.09M	–	1522
2017 Q2	$1.09M	Sell	2,266 -2,082	-48%	-$1.27M	﹤0.01%	1295
2017 Q1	$3.26M	Hold	4,348	–	–	﹤0.01%	1171
2016 Q4	$4.26M	Buy	+4,348	New	+$4.97M	﹤0.01%	1114

Other funds holding TCON

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Franklin Resources's TCON Position: Q2 2022 in Review

Franklin Resources sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2022, closing a stake of 2,185 shares — an estimated $115K sold.

Franklin Resources first reported a position in TCON in Q4 2016 and held it in 6 quarters. The position peaked at $4.26M in Q4 2016. 31 funds tracked by Wall St. Rank hold TCON as of Q2 2022.

Franklin Resources reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Franklin Resources sold 2,185 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $115K.
Franklin Resources first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q4 2016 and held it in 6 quarters.
Franklin Resources's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $4.26M in Q4 2016.
31 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Franklin Resources's 13F filing for Q2 2022, filed 11 Aug 2022.